Duchenne Muscular Dystrophy (DMD) Treatment Market
Highlighting Regional Revenue Share Dominance During
2018-2026
Duchenne muscular dystrophy (DMD) is a genetic disorder characterized by progressive muscle
degeneration and weakness. DMD is caused due to alteration in gene sequence coding for
dystrophin protein, which is present the muscle. It is a rare muscle disease which majorly
affects males. The symptoms includes intellectual disability, muscle weakness and, difficulty in
walking and breathing. Congestive heart failure, mental impairment, pneumonia or respiratory
failure are some of the complications of this disease. The treatment is available to control or
reduce the signs and symptoms as DMD is not curable. Steroid drugs are used to control the
symptoms of duchenne muscular dystrophy. Stem cell therapy and gene therapy could be used
for treatment of this disease in future.
For In depth Information Get Sample Copy of this Report @
https://www.coherentmarketinsights.com/insight/request-sample/898
Growing investments in the research and development, to find out effective treatment for DMD
is driving the growth of duchenne muscular dystrophy (DMD) treatment market:
According to the reports of Centers for Disease Control and prevention (CDC) 2007, 349 out of
2.37 million males in the United States were reported to be suffering from DMD. Whereas in
2019, 349 new cases of DMD were reported. Increasing incidences of DMD and requirement for
its treatment is driving the growth of duchenne muscular dystrophy treatment market. Various
organizations are involved in spreading awareness and investing in research and development to
find the effective treatment for this disease, which is contributing to the growth of duchenne
muscular dystrophy treatment market. For instance, Muscular Dystrophy Association (MDA), U.S.
invests 75000 USD in research and development to find out the treatment for duchenne
muscular dystrophy and the association funds more than 150 care centers, health care facility
centers, and hospitals across U.S. and other countries. Moreover, other factors, such as constant
research on stem cell therapy, gene therapy, and exon skipping drugs for the treatment of DMD
is expected to propel the growth of DMD treatment market. However, major restraints